Brand equity and tracking
Key driver analysis
Supporting all Ipsos Healthcare analytical frameworks: Segmentation
MEDICAL IMAGING
Industrial
Designers
HCI
Experts
Performance based
In-lab or In-field/mobile
Remote
Addressing key client questions
Does coding exist and will reimbursement be sufficient?
How will payers/purchasers (health plans, providers, facilities, etc.) view the technology? And what are their potential objections?
What is the competitive landscape and where are there opportunities for differentiation?
Which asset(s) should be prioritised and where does the strongest commercial potential lie?
What potential barriers to access and reimbursement exist, and how can they best be addressed?
Our main focus
Powered by four core services
Bio-Medical Engineers
Read Human Factors & UX Case Studies
Our MD&D-focussed Advisory Services experts support go-to-market and business optimisation
Model Input
Contact Us
See how we support Market Access &
HEOR insights across the MD&D lifecycle
What is the current competitive environment in my business sector and how is it likely to change? How is my company performing and positioned versus my competitors?
What are the impending threats or emerging opportunities which my company should be aware of?
Are there key success factors and best practices which our company could learn from top competitors in our market?
What are the strengths and weaknesses of my key competitors?
Are there any key developments which will affect or threaten our market position?
What are the strategic levers which should be deployed in order to strengthen our company’s position in the market?
And many more...
Hover over to explore
1.
2.
3.
4.
5.
6.
Strategy and design
Our expertise in Value Justification includes:
- Pricing and reimbursement strategy
- Launch pricing
- Negotiation and contracting strategy
- Negotiation toolkit development
- Innovative agreement and managed entry scheme
Insights
• Market sizing & forecasting
• Competitive intelligence
• Customer segmentation
• Innovation scouting
A cross-disciplinary team
• PACs
• Wearables
• Remote monitoring
• Health apps
• Digital therapeutics
Your MD&D Centre of Expertise
Discover everything we have to offer.
Building interactive dashboards for client deliverables
Tableau
Excel
Xcelsius
SURGERY
Key business questions
Advisory Services
Medical & HEOR strategy
Diseases landscape assessment
Primary cross-sectional & longitudinal research, e.g., registries
Clinical, payer and multistakeholder insight and advisory boards
RWE strategy
Syndicated RWE studies
Advanced Analytics
CONCEPT
Clinical justification
Economic case
Affordability and willingness to pay
Price, cost, budget impact and sustainability
Physician, patient & political pressure
Negotiation
Final validation the entire system is safe & effective
Clinical trial optimisation
Order of entry uptake modelling Pricing
Message optimisation
Right story
Right data
Right way
Right time
Right stakeholders
Primary Market Research
Ipsos' Medical Devices & Diagnostics (MD&D) Centre of Expertise provides end-to-end solutions to more effectively address your evolving needs. We have functional expertise in helping our clients understand the market landscape and identify growth opportunities.
We ensure strategic insights and recommendations across the product lifecycle, by combining the industry expertise of our 60-person MD&D team with best-in-class techniques and unparalleled global resources, supported by specialists from our broader group of 1,000 healthcare professionals.
Ipsos brings MD&D expertise you can trust: More than 15 years of experience, operating through four regional hubs (US, EU, LATAM, APAC), conducting 400+ projects a year and working in partnership with all 20 of the Top 20 MD&D companies.
Price optimisation/ wilingness to pay
optimising your business with our Advisory Services
marketing science
MARKET ASSESSMENT
Nursing & Clinical AdministratioN
Addressing key client questions
Addressing key client questions
How are developments in our business environment affecting the choices our customers make?
What factors affect our customers’ decision-making processes? What do they think of our business and how can our business serve them better?
How can we define segments within our business customers? Which segments should our business prioritise?
1.
2.
3.
4.
5.
Competitive intelligence
• Change management
• Strategic workshops
• Business unit strategy
DEVELOPMENT
© 2020 Ipsos All Rights Reserved
Experts in IEC 62366-1:2015, ANSI/AAMI HE75:2009 (R) 2013, US FDA regulations, FDA PMTA ENDS guidance, ISO 9001 certified
Concept evaluation and refinement
- Device prototype
- Marketing material
1.
2.
3.
4.
5.
6.
How do we find a business partner to oversee the distribution, sales and marketing of our product?
How can we be sure that potential business partners have a genuine interest in a new business partnership?
How do we build a model that will identify a broad list of potential partners and effectively filter the database until the best candidates are identified?
Hover over to explore
Read Advisory Services Case Studies
1.
2.
3.
4.
• Market entry strategy
• Partner evaluation
• Operational efficiency
• Distribution/channel strategy
Information Architects
Post-market
Disease burden
Treatment experience, current SOC and unmet need
Technology development stages
Evidence requirements and gap assessment
Iterative design
software
engineers
Data visualization
Market sizing and forecasting
• Hospital based multi-parameter monitors
• Hand held home devices (such as blood glucose monitors)
Market trends and drivers
CARDIOLOGY
Services
Forecasting
Etc.
Download our full brochure
Launch excellence
complete coverage & expertise across a range of
MD&D sectors
DRUG DELIVERY
Hover over icons to learn more
Prototyping
Expert review
Heuristic analysis
Information architecture
Visual design
Maximising your value story with our Market Access & HEOR
Clinical
Economic
Patient relevant
Societal
Political
Customer experience/satisfaction
- Customer loyalty
- Value optimisation strategies
- Customer segmentation
How big is the overall market today?
How rapidly is it growing?
What segments are most interesting?
What substitute products and services are our potential customers currently using?
What are the long-term demand forecasts broken down by volume and price?
Who will be our main competitors?
Contact Us
• Wound care
• Airway management
• Beds and tables
• Cleaning solutions, swabs
Commercial strategy
data science
• Invitro Diagnostics
• Point of Care
• Genomic
DEVELOPMENT
Dedicated to improving healthcare outcomes through strategic and insightful MD&D research & advisory services
1.
2.
3.
Primary Market Research
Partner evaluation solution
Leading the convergence of evidence, value & access
Value assessment
data science
Read Primary Market Research Case Studies
Partner evaluation solution
• Tools (manual and
energy based)
• Implants (e.g. hip and knee)
• Hernia mesh
• Scopes
• Robotic surgery
Part of the number one full-service global healthcare market research agency
Brand health tracking
- Advertising and messaging effectiveness/tracking
- Brand/channel/corporate equity measurement and tracking
Improvement based on user performance and hard data
LAUNCH/POST LAUNCH
CONNECTED HEALTH
Value assessment
Read Market Access and HEOR Case Studies
Our human-centred design offerings
LAUNCH/POST LAUNCH
INTERNAL DIAGNOSTICS
Data visualisation
Read Advisory Services Case Studies
Case Studies
B2B customer segmentation
Market Access & HEOR
introducing IPSOS' expert Medical Devices & Diagnostics team
research
Psychologists
FEASIBILITY
Our expertise in Evidence Generation includes:
- Medical & HEOR strategy
- Diseases landscape assessment
- Primary cross-sectional & longitudinal research, e.g., registries
- Clinical, payer and multistakeholder insight and advisory boards
- RWE strategy and Syndicated RWE studies
PATIENT MONITORING
Building interactive dashboards for client deliverables
Tableau
Excel
Xcelsius
Value justification
1.
2.
3.
4.
5.
6.
7.
Our expertise in Value Communication includes:
- Market/stakeholder archetyping
- Physician, patient and payer segmentation
- Value message/story development and testing
- Value communication tools
- Publications
- Multi-channel engagement strategy
Evidence generation
What is the expected level of effort and risk to gain reimbursement?
What is the perceived value of the intervention/diagnostic information?
What are the likely non-clinical, care delivery and health economic value proposition/claims?
What are the core unmet needs associated with the disease/product area?
Advisory Services
Value communication
See the key questions we will answer
INTERNAL DIAGNOSTICS
Ipsos offers MD&D-focussed primary research expertise to support you across the entire product lifecycle.
PARTNER EVALUATION is offered as a stand-alone service or as part of a go-to-market and business unit strategy solution
Key questions answered
Brand equity and tracking
Key driver analysis
Supporting all Ipsos Healthcare analytical frameworks: Segmentation
Competitive intelligence
Implementation
• MRI, CT, Fluoroscopy
• X-Ray, Mammography
• Ultrasound
• Advanced Molecular imaging
Forecasted Chart
CONCEPT
Discovery research
Has coding, coverage or reimbursement impacted adoption of our product?
What, if any, pushback have we received due to pricing?
What are the evidence development needs post-launch; real-world data to support our value story?
How do we communicate the value story?
How do we adapt the value story as the market changes?
Powering your strategies with our Primary Market Research
User & design specs Instruction for use Training materials Interface implementation
Stakeholder interviews Discovery workshops User analysis
FEASIBILITY
Human Factors & User Experience
WE PRIORITISE OPPORTUNITIES that strengthen your existing positioning and identify strategic levers to counter competitive threats
Experts
Read Market Access and HEOR Case Studies
Market sizing and forecasting
• Syringes
• Pens
• IV lines
• Infusion pumps
• Insulin pumps and Patches
• Dialysis
Market landscaping
- Stakeholder mapping
- Real-life decision making (HCP, Patient and Payer)
- Treatment algorithms
- Competitor footprint and performance
- Understanding unmet needs and market barriers
Performance optimisation
AI-based unstructured data analytics, e.g. text analytics of social listening data
Voice analytics
Cross-data source analytics
Big data analytics
Data fusion
Cloud computing
Market Access & HEOR
Commercial strategy
Our services don’t end there.
Performance optimisation
Brand equity and tracking
Key driver analysis
Supporting all Ipsos' healthcare analytical frameworks
Segmentation
Clinical trial optimisation
Order of entry uptake modelling
Pricing
Message optimisation
Forecasting
Value proposition/story refinement
- Launch strategy
Message positioning and performance
• Cardiac rhythm
• Coronary stents and associated devices
• Peripheral vascular devices
• Heart valves
• Cardiac ablation
• Cardiac monitoring/imaging
Driving your human-centred design with our Human Factors & Ux
CLINICAL DIAGNOSTICS
Human Factors & User Experience
Value communication
Our MD&D-focussed Market Access & HEOR experts support insights for your key business questions
AI-based unstructured data analytics, e.g. text analytics of social listening data
Voice analytics
Cross-data source analytics
Big data analytics
Data fusion
Cloud computing
1.
2.
3.
Evidence generation
Human Factors Engineers
HOSPITAL SUPPLY
What data will be required to support a positive coverage policy?
What data will be required to support premium pricing (if desired)/our value story?
Is there a need for economic data and/or models to support value?
What value messages resonate most strongly, and how do messages vary by stakeholder type or segment?
What is our go-to-market access strategy?
Commercial strategy
Commercial strategy
Contact Us
Services to address key business questions
Commercial strategy
Our expertise in Value Assessment includes:
- Core reimbursement dossiers
- Cost effectiveness, cost utility and budget impact modelling
- HTA submissions
- Health policy research
- Willingness to pay studies
Launch excellence
Pricing and reimbursement strategy
Launch pricing
Negotiation and contracting strategy
Negotiation toolkit development
Innovative agreement and managed entry scheme
IMPLEMENTATION
Market/stakeholder archetyping
Physician, patient and payer segmentation Value message/story development and testing
Value communication tools
Publications
Multi-channel engagement strategy
1.
2.
3.
4.
5.
Market assessment
A STEPWISE PROCESS OF SEGMENTATION so that your business can understand the universe of customer segments and identify the right segments to target
User needs identification/development | Digital, connected devices, mobile & web design | Device & platform evaluation/test | Usability & systems engineering support
Validation
(summative testing)
Value justification
Design evaluation
(Formative testing)
Addressing key client questions
Read Primary Market Research Case Studies
B2B customer segmentation
How do we make sure that the market entry strategy suits our business model and targeted customers?
How do we create a compelling value proposition addressing the needs of our customers?
What is the size of the potential opportunity in our specific market?
What should be our practical roadmap for the launching of our portfolio in our market?
How should we set our growth KPIs? Should we focus our business strategy on growing market share, increasing penetration, or finding a new niche?
Which potential partners are best suited to help our business compete more effectively?
1.
2.
3.
4.
5.
Core reimbursement dossiers
Cost effectiveness, cost utility and budget impact modelling
HTA submissions
Health policy research
Willingness to pay studies
Concept evaluation and refinement
- Device promotype
- Marketing material
© 2020 Ipsos All Rights Reserved
The resulting IFU and Quick Tips for the device were optimized and concise.
The Formative Testing, IFU and Quick Tips resulted in a successful Summative Test.
The product launched successfully with FDA approval.
SITUATION
outcomes
Client
Therapy area
ENT
A major medical device manufacturer wanted to understand post-market delivery for an auto-injector for arthritis sufferers in order to support device claims. The objectives were to evaluate the product’s ease of use in usability, learnability, confidence self-injecting, and ergonomics.
Primary research: global
Scope
Ipsos worked with the client on several workstreams to achieve the client’s objectives. First, Ipsos conducted desk research to understand the capital equipment buying process in select global markets.
Following onto that, Ipsos conducted in-depth 1:1 interviews with hospital-based non-clinical decision-makers to further explore the buying process and better understand the evidence needs and criteria for large capital equipment purchases.
The autoinjector was well-received and participants were complimentary towards it. Results and analysis included the extent of potential users’ agreement with prepared claims, and any questions they had after simulated use of the product.
Market assessment and forecasting of global FISH molecular diagnostics market
Oncology
SITUATION
United States; applies globally
The resulting Users Manuals were optimized for ease of use.
The Formative Testing and Users Manuals resulted in a successful Summative Test.
The product was launched successfully with regulatory approval.
Therapy area
Cardiac Implantable Electronic Devices (CIED) optimization research
case study 3
SITUATION
SITUATION
SITUATION
Contact Us
Having established eight separate market needs, each of the potential solutions were evaluated during a quantitative research phase.
Each product offering was measured against relevance, demand, potential to meet KPI’s and likelihood of adoption.
APPROACH
Client
Therapy area
The outcome of our study provided our client with clear and actionable insights, which directly fed into their marketing strategy.
Based on our findings we were able to outline key priority areas of future technology needs recommending which solutions to invest in and bring to market. Through identifying key stakeholder profiles, our client created targeted marketing materials using the optimum communication channels uncovered through our study. Our client’s sales team was supported by the adoption pathway mapping created as part of the deliverables. Having established potential barriers to uptake, go-to-market strategies were put in place to mitigate these obstacles.
Delivered through a workshop-style debrief, insights into each topic was disseminated across stakeholders within our client’s organization. Our collaboration facilitated maximum product adoption within the priority markets outlined in our recommendations.
Our client was in the process of expanding their device portfolio as well as their wider managed services offer. As such, the primary business objective was to establish current and future technology needs within the cardiac care space.
Potential solutions included interventional devices supporting remote monitoring, continuous monitoring, connected health applications as well as patient data and information flow solutions.
Key objectives of this study were:
- Unmet needs analysis
- Market potential scoping and access
- Key stakeholder analysis
- Identification of drivers and barriers to uptake
case study 3
APPROACH
Global
case study 2
SITUATION
outcomes
Understanding current landscape and payer’s perspective via primary and secondary research
EU5: France, Germany, Italy, Spain and United Kingdom
outcomes
This work helped inform strategic decisions around attractiveness of therapy area and shortlist potential targets for due diligence.
SITUATION
SITUATION
Our client wanted to [1] understand digital health landscape and payer partnerships in key markets; and [2] assess payer perceptions of patient-facing digital solutions generally, and target product concepts specifically, in the US and UK.
NIPT
SITUATION
APPROACH
Multiple
Therapy area
Strategy for robotic capital equipment
Understanding current landscape and payer’s perspective via primary and secondary research
Future technology needs within cardiac care
SITUATION
SITUATION
outcomes
Global diagnostics company
Results and analysis included neurologists’ appetite for the digital platform, identification of most appealing features and recommendations for improvement based on actual user data.
case study 4
Primary respondent targets included Heads of Cardiology, Interventional Cardiologists and hospital budget holders. These groups were interviewed during an initial qualitative research phase.
Robotic surgery
US-based medical devices company
Scope
SITUATION
Our team evaluated the risk analysis to incorporate correct device use, actual use errors from formative studies, and important informational notes to improve device iterative design, and create an effective IFU and Quick Tips design.
Therapy area
Desk research sought to answer two key business questions: [1] ‘What is the current landscape for consumer-facing digital offerings?’ and [2] ‘What are payers investing in?’
SITUATION
A major neuroscience pioneer wanted to assess and improve their digital platform, enabling neurologists to stay current on medical information.
Influential global organizations:
- WHO (World Health Organization)
- CHAI (Clinton Health Access Initiative)
- FIND (Foundation for Innovative New Diagnostics)
- PATH
- USAID (United States Agency for International Development)
- STOP TB Partnership
- MSF (Médecins sans Frontières)
Next, qualitative interviews were facilitated with high-prescribing physicians and glaucoma patients to map the treatment journey, assess patient ability/willingness to pay and delineate cost and funding structure for glaucoma surgery.
Oncology
Global devices manufacturer
We analyzed insights from all stages of the engagement to formulate conclusions and recommendations.
case study 3
case study 4
case study 1
outcomes
APPROACH
APPROACH
Scope
Device
Ophthalmology
Therapy area
APPROACH
case study 3
outcomes
Scope
outcomes
We conducted internal stakeholder discussions to narrow scope to CRS (Chronic Sinusitis and Rhinitis) space within ENT.
Experts
Global medical equipment company
outcomes
Large-scale understanding of tuberculosis (TB) diagnostics outlook and reception of new rapid-testing diagnostic kit
Performed remote formative sessions with users over three days. Users were asked to sign up for an account, interact with multiple platform features, and provide feedback.
Two consultants facilitated the 60-minute study sessions, gathered performance and user data and captured trends.
outcomes
Our team evaluated the risk analysis to incorporated correct device use, actual use errors from formative studies, and important informational notes to improve device iterative design, and create effective Users Manuals for each user group.
EU5
APPROACH
Hong Kong, Malaysia, Philippines, Singapore, Thailand, Vietnam
case study 1
APPROACH
© 2020 Ipsos All Rights Reserved
Case Studies
Our services don’t end there.
SITUATION
outcomes
case study 2
US
Human Factors & Ux
Global market leading company in diagnosis and monitoring
Human Factors & User Experience
Oncology
SITUATION
Ipsos performed 60 in-lab, one-on-one interviews with users over four days, across four cities. Two consultants, facilitated the 30-minute study sessions, gathering feedback and impressions of the product. Users were instructed on the product’s use, given a chance to simulate use of the device using a practice injection pad, and provided feedback in the form of their agreement with a series of prepared statements on a 5-point Likert scale.
We provided a strategic five-point action plan to support our client to optimize the commercial opportunity of their innovative device in Southeast Asia. The action plan is well supported by the resulting outputs and endorsed by our client, in which a “controlled launch” approach was taken to prioritize the mature markets.
Global pharmaceutical company
APPROACH
Client
outcomes
Scope
Global pharmaceutical company
Scope
case study 1
outcomes
SITUATION
outcomes
US mix of self-funded employers and health plan roles
In preparation of our client’s launch of their new CIED, they aimed to gain further insights into the features that will create the most compelling offering. The primary objectives of this research were:
- Understand which features add the most value and create the ideal device configuration
- Estimate expected uptake upon launch, under varying product configurations
- Determine potential impact on other CIED implant volume
- Identify the types of patients implanters perceive as most likely to benefit
- Measure differences in the above metrics by region
The results of this research provided our client with an increased understanding of non-clinical hospital stakeholder decision-making for a new capital equipment used during robotic surgery, while maintaining and improving relationships with these key stakeholders. Ipsos continues to assist this client in engagement with the advisors in a collaborative effort to gather impactful non-clinical insights and inform commercialization strategy.
UK mix of private and public payers
outcomes
APPROACH
Client
Client
The quantitative survey included an allocation-based conjoint exercise to inform an optimized product configuration, and a patient profile exercise that included a point allocation to identify patient types for our client’s CIED.
Our client wanted to understand the TB diagnostics situation in several markets globally and to construct route-to-market strategies for their rapid-testing capability:
- Understanding key TB challenges in treatment and, especially, diagnostics at global and country level
- Gain insights on clinical/public health professionals’ key motivations and priorities in TB diagnostics
- Evaluate current diagnostic methods vs. client’s
- Understand critical buying and funding processes to ensure effective partnerships
- Obtain opinions, feedbacks on pricing model, improvements to develop effective receptivity
Global Pharmaceutical company
In-depth interviews with 35 payers (20 US and 15 UK) with experience evaluating and/or implementing member-facing digital health solutions
Market Access & HEOR
US, EU5
Insights from this study helped inform the client’s understanding of current market for digital solutions in health. The client is now clear on how to best partner with US and UK payers and what data would be required to support their current product concepts.
Global medtech company
outcomes
Improving a digital platform
SITUATION
SITUATION
APPROACH
Market Access & HEOR
Ipsos utilized a phased approach to address the client‘s needs:
Phase 1: In-depth interviews and dyad/triads, in four countries with physicians, nurses and respirtory therapists.
outcomes
Global + deep dives in US and EU5 markets
APPROACH
SITUATION
Client
Due to increased competitiveness from newer generation technologies, the client wanted to assess the Oncology molecular diagnostic market with specific focus on fluorescent in situ hybridization (FISH).
Specifically, there was interest to understand the diagnostic landscape in bladder, breast, hematological, and lung cancers, across key global markets.
Strategy for robotic capital equipment
SITUATION
APPROACH
Cardiology
Client
Therapy area
APPROACH
outcomes
Client
Pricing optimization for an innovative device for glaucoma surgery
Therapy area
We took the final system into Summative Testing to show the device was safe and effective.
We took the final system into Summative Testing to show the device was Safe and Effective.
case study 4
Our client was preparing to launch an innovative device for a novel glaucoma surgery in Southeast Asia. There was a need to gain a thorough understanding of the complex funding mechanisms across the 6 in-scope countries in order to optimize the launch price of their innovative device.
case study 4
Global medical device company
Therapy area
Our report delivered actionable insights and evidence-based, strategic recommendations that the proposed new device addressed unmet needs and improved the process for both HCP and patient.
Unmet needs addressed by the preferred prototype include safety, sample quality, ease of use and patient experience.
Additionally, research revealed that standard protocols are not universally followed, leading to errors, deviations, inconsistencies and bad practices, which have become engrained at nearly every step of the procedure.
Adoption of the new device, with corresponding protocol training, will improve the potential to minimize risks, address unmet needs and improve the experience for patients and HCPs.
APPROACH
APPROACH
Global devices manufacturer
SITUATION
Global devices company
Therapy area
Therapy area
Diagnostic
outcomes
EU5 health economic model & value communication strategy for NIPT
APPROACH
We reviewed existing client/Ipsos materials and conducted an affiliate listening exercise to understand region/country priorities and information gaps.
Client
Therapy area
APPROACH
49 qualitative face-to-face and telephone interviews in 5 regions; China, India, Indonesia, Brazil, Africa (3 countries) and global health organizations.
Range of TB experts: Ministry of Health/CDC officials, infectious diseases hospital heads, TB KOLs, end-users (clinic/lab physicians and head technicians).
Global
APPROACH
APPROACH
We used a combination of secondary research, client’s internal data and a quantitative survey across EU5 markets among interventional oncologists to better understand:
- Market size and shares of IO treatments
- Trends and drivers/barriers of IO procedures
- Future growth of IO procedures and products for the next five years
We used a combination of secondary research, discussions with KOL/ENT specialists to better understand:
- Disease/treatment overview
- Market landscape assessment
- Identification and profiling of potential products/companies for M&A along with a high-level, outside-in assessment
case study 2
Global medical device manufacturer
outcomes
Scope
Then, we conducted quantitative surveys with high-prescribing physicians to assess patient load, value drivers/barriers (MaxDiff) and pricing potential (Conjoint) considering patient willingness-to-pay and available funding.
Case Studies
Therapy area
case study 1
outcomes
APPROACH
outcomes
A major pharmaceutical company needed to:
- Evaluate hardware and software for a connected health solution
- Develop a Users Manual for patients, healthcare support, and physicians
- Validate the entire system for regulatory approval
Neurology
Scope
Market and competitive overview
United States
Therapy area
Global technology company
SITUATION
New device concept evaluation to improve hospital process
We conducted a desk research and primary research program with key stakeholders (payers and clinicians) to inform the overall HE strategy and model.
Our HEOR and value communication experts created a portfolio of value materials and designed a training program to prepare the client.
Our client had recently divested a large part of their business to transform into a pure-play medical devices business.
After de-leveraging, company wanted to deploy funds to drive strategic M&A to extend its leadership in core franchises and expand into attractive adjacencies.
The client asked Ipsos’ help to identify companies that could be attractive M&A targets for them in the ENT segment.
APPROACH
outcomes
SITUATION
Scope
case study 2
Connected health
APPROACH
Scope
outcomes
EU5 + Netherlands
Additionally, Ipsos organized and facilitated non-clinical advisory boards engagements including: two in-person meetings in the US and EU and two follow-up teleconferences.
During the advisory board meetings, Ipsos facilitated mock value analysis committee decision-making sessions and further tested the value propositions for non-clinical stakeholders.
outcomes
Global devices manufacturer
SITUATION
outcomes
Market size and shares (by technology and geography)
Ipsos designed a two-phased research approach in order to build and test assumptions based on current market understanding.
Contact Us
Advisory Services
Our client was able to gain valuable insights on the TB diagnostic landscape, both in the individual and the global level, permitting them to develop practical strategies for their product across the TB-prevalent countries around the globe.
Specifically:
- Developing unique strategies undertaking country-specific barriers to realize market potential
- In-depth understanding of various funding networks, both global and local to further expand leverage
- Contrasting existing diagnostics to further complement and develop value-adding proposals to TB programs globally and locally
- Assess pricing feasibility and obtain feedbacks to further develop and strategize client’s entrance globally and locally
Primary research: US, UK
Secondary research: US, EU5, BRIC
SITUATION
Client
Primary research: global
25-minute double-blinded online survey in the US, UK, France, Germany, Italy, Spain, the Netherlands, Japan and Australia.
A total sample size of 440 CIED implanters.
SITUATION
SITUATION
outcomes
Our client sought support for establishing the global commercialization strategy for a new capital equipment used during robotic surgery. As part of this strategy, our client was particularly focused on the decision-making process for non-clinical stakeholders to ensure a clear understanding of the buying process for large capital equipment purchases.
Our client sought to formulate a HE modeling and value communication strategy to promote coverage and reimbursement of NIPT across EU5 public insurance systems. Healthcare systems vary across EU5 markets, therefore it was imperative to craft an overall HE model and value communication strategy with a core framework, while developing an Excel-based model and communication materials with the flexibility to adapt to each market’s unique aspects.
Additionally, our client sought an Ipsos-led internal training program to train their market development and field teams in preparation for stakeholder meetings.
outcomes
SITUATION
Phase 2: In-depth, in-person interviews in three countries with physicians, nurses and respiratory therapists.
SITUATION
Cardiac rhythm
Client
Digital health
Market attractiveness and target identification (for M&A) in ENT segment
Primary research: global
The research methodology was comprised of desk research for 10 countries and primary research with payers in the US and UK. The two streams of research were integrated to share the findings across markets and comparatively.
Our client sought to develop a global hospital value story, confirming unmet needs and exploring new solutions for a medical test.
Research topics included: Current experience with the current process/technique, confirming unmet needs, evaluation of new prototypes and features and assess willingness to consider.
APPROACH
Review select success stories from across a variety of recent MD&D projects
Through importance and current satisfaction with device-related factors, Ipsos identified key unmet needs and where the new CIED is perceived to be more favorable.
With the conjoint analysis, Ipsos identified optimal configurations for our client’s new CIED globally and across regions. The analysis also enabled a head-to-head comparison versus potential competitors.
A patient profile exercise allowed for Ipsos to identify how certain patient characteristics affected the devices implanted into a patient, and the variations of these characteristics across markets.
Scope
Primary Market Research
Scope
Improving a digital platform
We delivered a comprehensive suite of value services, including:
- Formulation of HE model and value communication strategy & framework
- Dynamic EU5 health economic model with market-specific inputs and field access capture sheet
- Comprehensive HE model report
- Five market-specific, executive NIPT value stories
- In-person internal training program
APPROACH
case study 4
Formative, summative and instruction for use (IFU) design for a medical device
Client
outcomes
Services
Insights from our work fed into the strategic planning process and helped inform commercial/R&D strategies to prioritize focus areas and help drive future growth.
Scope
Our work played a critical role in informing strategic portfolio and M&A/divestiture decisions for the client’s interventional oncology portfolio in EU5 markets.
Primary Market Research
Scope
APPROACH
Post-market analysis to support device claims
APPROACH
We used a combination of secondary research, KOL interviews (by region), client’s historical data and Ipsos’ proprietary syndicated data to develop:
Market sizing of interventional oncology category for liver cancer (HCC & mCRC)
Client
Contact Us
APPROACH
The client’s strategic objective was to identify product categories where it has/could be among the Top 3 players in EU.
To do this, they asked us to help them better understand the current dynamics in interventional oncology and recommend the areas of focus for their BU.
Further, they also wanted a custom market model with current and future market size by tumor type, by procedure type and by market.
Advisory Services
Arthritis
Market size and shares (by technology and geography)
case study 1
Client
Client
A major pharmaceutical company needed to:
- Evaluate various design options early in the development cycle
- Develop an Instructions for Use (IFU) and a Quick Tips guide to ensure safe use of the device
- Validate the entire system for FDA approval
outcomes
APPROACH
APPROACH
Therapy area
Discover everything we have to offer.
outcomes
Scope
SITUATION
Market and competitive overview
Download our full brochure
Insights
© 2020 Ipsos All Rights Reserved
Lorem Ipsum
Learn More
Contact Us
Learn More
Learn More
Lorem Ipsum
47%
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
HFES
Lorem Ipsum
Download our full brochure
Lorem Ipsum
Discover everything we have to offer.
ADVAMED
Experts
Quarterly Pulse Reports
Download Report
Learn More
USA
Pulmonology
Download Report
Learn More
Insights
USA
Ophthalmology
GENERAL SURGERY
Lorem Ipsum
WHITE PAPER
Download Report
Explore relevant and timely MD&D data and insights through our regular Pulse Reports, as well as webinars and white papers
RADIOLOGY
53%
Five simple maneuvers for maximizing your medtech launch plan, boosted by market access intelligence
Learn More
China
whitepaper
Discover everything we have to offer.
whitepaper
17%
Lorem Ipsum
Download our full brochure
13%
HLTH
28%
What trends will have a significant impact on the diagnostics landscape?
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
Download Report
Higher accuracy of genomic sequencing
Machine learning using algorithms
Automation tech enabling higher throughputs
Robotization of clinical diagnostics
Advances in data anlytics/big data sets
Cloud computing enabling research
Features input from 125 Pathologists in the US & EU
webinar
Features input from 125 Pathologists from the EU & US
Case Studies
© 2020 Ipsos All Rights Reserved
Contact Us
Europe
Learn More
Webinars and White Papers
Europe
Download Report
webinar
whitepaper
Quarterly Pulse Reports
SHARPENING PHYSICIAN INSIGHTS BY INTEGRATING PATIENT RECORD AUDITING
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
Learn More
FEBRUARY 2020
21-country study of 1,745 physicians' perceptions of digital & connected health
Learn More
Play Recording
45%
How many patients are using remote monitoring systems?
APRIL 2020
DIABETES
aug 18
JANUARY 2019
FUTURE OF healthcare Diagnostics
OCTOBER 2018
Features input from 402 Ophthalmologists across 11 countries
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
China
17%
JUNE 2019
aug 18
Features input from 240 Pulmonologists across 7 countries
Read White Paper
21%
28%
NOVEMBER 2019
37%
Maximizing your medtech launch plan
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
Europe
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
Download Whitepaper
35%
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
Contact Us
Join our MD&D, Connected Health & Access experts in Las Vegas, Oct. 11-14
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
Industry events
aug 18
Lorem Ipsum
oct
6
aug 18
Our services don’t end there.
aug 18
oct
5
Insights
Join our MD&D, Connected Health and Access teams in Toronto, Oct. 5-7
Contact Us
2018 vs. 2020
Ipsos partners with SERMO to conduct a series of Rapid Research pulse studies, each with a different group of healthcare professionals
Play Recording
Download Whitepaper
47%
webinar
Lorem Ipsum
Join our MD&D, Human Factors & User Experience experts in Chicago, Oct. 6-9
Download Report
Integrating patient record auditing for increased accuracy and specificity
DIGITAL DOCTOR 2020
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
Lorem Ipsum
28%
13%
Webinars and White Papers
18%
Features input from 163 Radiologists in 7 countries, benchmarked to 2017 data
Industry Events
Download Whitepaper
Lorem Ipsum
China
aug 18
Our services don’t end there.
18%
oct 11
21%
28%
Features input from 279 General Surgeons across 9 countries
USA
6 in 10 pathologists agree
Features input from 398 Endocrinologists across 11 countries, benchmarked to 2018 data
Sharpening physician insights: Integrating patient record auditing
Download White Paper
Services
Features input from 398 Endocrinologists across 11 countries, benchmarked to 2018 data
Contact Us
© 2020 Ipsos All Rights Reserved
